China SXT Pharmaceuticals
SXTC
SXTC
4 hedge funds and large institutions have $133K invested in China SXT Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$108K |
| 2 |
VF
2
Virtu Financial
New York
|
$24K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$261 |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $108K | 62,599 | +57,329 | +1,088% |
|
|
VF
2
Virtu Financial
New York
| $24K | 13,970 | +13,970 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $261 | 151 | +151 | New |
|
4
Acadian Asset Management
Boston,
Massachusetts
| $0 | 48 | – | – |
|